CRB-601 monoclonal antibody
CRB-601-01
Phase 2 small_molecule active
Quick answer
CRB-601 monoclonal antibody for Solid Tumor is a Phase 2 program (small_molecule) at Corbus Pharmaceuticals Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corbus Pharmaceuticals Holdings
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active